Table 5 Changes from Baseline in Capillary Glucose and Venous Insulin Levels After a 70 g Sucrose Challenge With and Without Simultaneous Consumption of LA-Cr for Pilot Study (N = 20) and Clinical (N = 50).

% Difference Between Treatment vs Control

-22.3%

-26.0%

-43.2%

-43.5%

-31.4%

Significance Levels

P < 0.007

P < 0.001

P < 0.001

P < 0.031

P < 0.0001

Clinical Study N = 50 (Glucose Only)

Minutes from Baseline (Glucose)

30

45

60

90

AUC

% Difference Between Treatment vs Control

-19.1%

-26.1%

-24.8%

-27.1%

-18.4%

Significance Levels

P < 0.01

P < 0.001

P < 0.01

P < 0.05

P < 0.0001

Clinical Study N = 49 (Insulin Only)

Minutes from Baseline (Insulin)

30

60

AUC

% Difference Between Treatment vs Control

-11.9%

-28.3%

-28.3%

Significance Levels

NS

P < 0.001

P < 0.01